99282-6

LOINC 2.82

FDA product label FDA-initiated compliance action drug registration and listing inactivation - animal drug

FDA animal drug+list inactivation

Definition

  • When a pharmaceutical company discontinues the marketing of a product, it is required to send the FDA an Structured Product Labeling (SPL) file to indicate their intention to stop selling the drug. If no SPL file is received by a certain time, the FDA inactivates the drug listing. The information is purged from the FDA database in order to eliminate outdated information.

Component

  • FDA-initiated compliance action drug registration and listing inactivation - animal drug

Specimen / system

  • ^FDA product label

Class

  • DOC.REF

Property

  • -

Scale

  • Nar

Related names

  • DOCUMENT.REF; Drugs; FDA compl action drug and list inact; FDA drug+list inactive - animal drug; FDA label; Narrative; Report

Index terms

  • DOCUMENT.REF
  • Drugs
  • FDA compl action drug and list inact
  • FDA drug+list inactive - animal drug
  • FDA label
  • Narrative
  • Report